The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
Open accessAbstract
Although metformin is widely used for the treatment of non-insulin-dependent diabetes, its mode of action remains unclear. Here we provide evidence that its primary site of action is through a direct inhibition of complex 1 of the respiratory chain. Metformin (50 μM) inhibited mitochondrial oxidation of glutamate+malate in hepatoma cells by 13 and 30% after 24 and 60 h exposure respectively, but succinate oxidation was unaffected. Metformin also caused time-dependent inhibition of complex 1 in isolated mitochondria, whereas in sub-mitochondrial particles inhibition was immediate but required very high metformin concentrations (K0.5, 79 mM). These data are compatible with the slow membrane-potential-driven accumulation of the positively charged drug within the mitochondrial matrix leading to inhibition of complex 1. Metformin inhibition of gluconeogenesis from L-lactate in isolated rat hepatocytes was also time- and concentration-dependent, and accompanied by changes in metabolite levels similar to those induced by other inhibitors of gluconeogenesis acting on complex 1. Freeze-clamped livers from metformin-treated rats exhibited similar changes in metabolite concentrations. We conclude that the drug's pharmacological effects are mediated, at least in part, through a time-dependent, self-limiting inhibition of the respiratory chain that restrains hepatic gluconeogenesis while increasing glucose utilization in peripheral tissues. Lactic acidosis, an occasional side effect, can also be explained in this way.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metformin may cause lactic acidosis through impairment of oxidative phosphorylation.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [464]
In the citing paper
“it has been shown to accumulate in mitochondria due to the membrane potential across the mitochondrial inner membrane”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Owen et al. 2000
In the citing paper
“However, metformin, one of the commonly prescribed drugs for treating type II diabetes, is safe despite acting as a mitochondrial complex I inhibitor that impairs respiration (Bridges et al., 2014; El-Mir et al., 2000; Owen et al., 2000; Wheaton et al., 2014).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Owen et al., 2000
In the citing paper
“This inhibition would in turn decrease the ATP/AMP ratio activating AMPK (127–129).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“As pointed out by Fontaine, a problem associated with accepting the argument that the therapeutic effects of metformin result from inhibition of complex 1, as depicted in Figure 1, are the high concentrations used in the cell culture studies described by El Mir et al. and Owen et al. (127, 128, 133).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“Given the evidence that metformin acts through the mitochondrial electron transport chain (ETC) by inhibiting complex I(46, 210–212) (Figure 8)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [210]
Citations
Cites
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Ebert, B. L., Firth, J. D., & Ratcliffe, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29083 · Cited by 569
Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse
Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418
Hundal, H. S., Ramlal, T., Reyes, R., Leiter, L. A., & Klip, A. (1992) · Endocrinology · doi:10.1210/endo.131.3.1505458 · Cited by 243
Perriello, G., Misericordia, P., Volpi, E., Santucci, A., Santucci, C., Ferrannini, E., Ventura, M. M., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1994) · Diabetes · doi:10.2337/diab.43.7.920 · Cited by 227
Argaud, D., Roth, H., Wiernsperger, N. F., & Leverve, X. M. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17886.x · Cited by 151
Biguanide-associated lactic acidosis. Case report and review of the literature
Gan, S. C. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.11.2333 · Cited by 129
Halestrap, A. P. (1987) · Biochemical Journal · doi:10.1042/bj2440159 · Cited by 120
Self-citationFischer, Y., Thomas, J., Rosen, P., & Kammermeier, H. (1995) · Endocrinology · doi:10.1210/endo.136.2.7835271 · Cited by 114
Cited by
Sorted by citations
Items 801–900 of 1,008
Qiu, B., Turner, N. A., Li, Y., Gu, M., Huang, M., Wu, F., Pang, T., Nan, F., Ye, J., Li, J.-Y., et al. (2009) · Diabetes · doi:10.2337/db09-0223 · Cited by 50
Lewis, A., Miller, J. J. J. J., McCallum, C., Rider, O. J., Neubauer, S., Heather, L. C., & Tyler, D. J. (2016) · Diabetes · doi:10.2337/db16-0804 · Cited by 50
Gallez, B., Neveu, M.-A. C., Danhier, P., & Jordan, B. F. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.002 · Cited by 50
Linking bioenergetic function of mitochondria to tissue-specific molecular fingerprints
Kappler, L., Hoene, M., Hu, C., von Toerne, C., Li, J., Bleher, D., Hoffmann, C., Böhm, A., Kollipara, L., Zischka, H., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00088.2019 · Cited by 52
Diot, A., Hinks-Roberts, A., Lodge, T., Liao, C., Dombi, E., Morten, K., Brady, S., Fratter, C., Carver, J. G., Muir, R., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.014 · Cited by 52
Why the endothelium? The endothelium as a target to reduce diabetes-associated vascular disease
Triggle, C. R., Ding, H., Marei, I., Anderson, T. J., & Hollenberg, M. D. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2019-0677 · Cited by 49
Biguanides drugs: Past success stories and promising future for drug discovery
Grytsai, O., Myrgorodska, I., Rocchi, S., Ronco, C., & Benhida, R. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113726 · Cited by 51
microRNAs and cancer metabolism reprogramming: the paradigm of metformin.
Pulito, C., Donzelli, S., Muti, P. C., Puzzo, L., Strano, S., & Blandino, G. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.06.03 · Cited by 49
Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia
Wu, N., Sarna, L. K., Siow, Y. L., & Karmin, O. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00441.2010 · Cited by 49
Dupuy, F., Griss, T., Blagih, J., Bridon, G., Avizonis, D. Z., Ling, C., Dong, Z., Siwak, D. R., Annis, M. G., Mills, G. B., et al. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-18 · Cited by 53
Stress-Adaptive Response in Ovarian Cancer Drug Resistance
Amoroso, M. R., Matassa, D. S., Agliarulo, I., Avolio, R., Maddalena, F., Condelli, V., Landriscina, M., & Esposito, F. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.01.004 · Cited by 50
Regulation of organelle function by metformin
Kim, J., & You, Y. (2017) · IUBMB Life · doi:10.1002/iub.1633 · Cited by 50
Li, Q., Zhou, T. J., Wu, F., Li, N., Wang, R., Zhao, Q. S., Ma, Y., Zhang, J., & Ma, B. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1512614 · Cited by 49
Metformin: A Potential Therapeutic Tool for Rheumatologists
Salvatore, T., Pafundi, P. C., Galiero, R., Gjeloshi, K., Masini, F., Acierno, C., Martino, A. D., Albanese, G., Alfano, M., Rinaldi, L., et al. (2020) · Pharmaceuticals · doi:10.3390/ph13090234 · Cited by 50
Kristensen, J. M., Larsen, S., Helge, J. W., Dela, F., & Wojtaszewski, J. F. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053533 · Cited by 48
PYK2 promotes HER2-positive breast cancer invasion
Al-Juboori, S. I. K., Vadakekolathu, J. N., Idri, S., Wagner, S., Zafeiris, D., Pearson, J. R. D., Almshayakhchi, R., Caraglia, M., Desiderio, V., Miles, A. K., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1221-0 · Cited by 48
Metabolic targeting of cancer by a ubiquinone uncompetitive inhibitor of mitochondrial complex I
Jain, S., Hu, C., Kluza, J., Ke, W., Tian, G., Giurgiu, M., Bleilevens, A., Campos, A. R., Charbono, A., Stickeler, E., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.11.002 · Cited by 48
Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy
Kumar, R., Mishra, A., Gautam, P., Feroz, Z., Vijayaraghavalu, S., Likos, E., Shukla, G. C., & Kumar, M. (2022) · Cancers · doi:10.3390/cancers14215268 · Cited by 50
Damanhouri, Z. A., Alkreathy, H. M., Alharbi, F. A., Abualhamail, H., & Ahmad, M. S. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.77206 · Cited by 49
Parkinson's disease and glucose metabolism impairment
Chen, L., Wang, C., Qin, L., & Zhang, H. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00467-8 · Cited by 51
Contributions of AMPK and p53 dependent signaling to radiation response in the presence of metformin
Muaddi, H., Chowdhury, S., Vellanki, R. N., Zamiara, P., & Koritzinsky, M. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.014 · Cited by 51
LKB1 tumor suppressor: Therapeutic opportunities knock when LKB1 is inactivated
Zhou, W., Zhang, J., & Marcus, A. I. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.06.002 · Cited by 48
Bright renoprotective properties of metformin: beyond blood glucose regulatory effects.
Nasri, H., Baradaran, A., Ardalan, M., Mardani, S., Momeni, A., & Rafieian‐Kopaei, M. (2013) · Iranian Journal of Kidney Diseases · Cited by 48
Impact of Concurrent Medication Use on Pancreatic Cancer Survival—SEER-Medicare Analysis
Beg, M. S., Gupta, A., Sher, D. J., Ali, S., Khan, S. A., Gao, A., Stewart, T. F., Ahn, C. W., Berry, J. D., & Mortensen, E. M. (2017) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000359 · Cited by 48
Padmapriyadarsini, C., Bhavani, P. K., Natrajan, M., Ponnuraja, C., Kumar, H., Gomathy, S., Guleria, R., Jawahar, S. M., Singh, M., Balganesh, T. S., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024363 · Cited by 49
Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in Macrophages
Liu, W., Bai, F., Wang, H., Liang, Y., Du, X., Liu, C., Cai, D., Peng, J., Zhong, G., Liang, X., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900117 · Cited by 49
Lord, S., Collins, J. M., Cheng, W., Haider, S. A., Wigfield, S., Gaude, E., Fielding, B. A., Pinnick, K. E., Harjes, U., Segaran, A., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0665-5 · Cited by 49
The Metabolic Interplay between Cancer and Other Diseases
Le, A., Udupa, S., & Zhang, C. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.10.012 · Cited by 48
Liang, Z., Zhang, T., Zhan, T., Cheng, G., Zhang, W., Jia, H., & Yang, H. (2021) · Journal of Neurophysiology · doi:10.1152/jn.00417.2020 · Cited by 48
Top, W. M. C., Kooy, A., & Stehouwer, C. D. A. (2022) · Pharmaceuticals · doi:10.3390/ph15030312 · Cited by 51
Erickson, M. L., Allen, J. M., Beavers, D. P., Collins, L. M., Davidson, K. W., Erickson, K. I., Esser, K. A., Hesselink, M. K. C., Moreau, K. L., Laber, E. B., et al. (2023) · GeroScience · doi:10.1007/s11357-022-00668-3 · Cited by 47
Mitochondrial Inhibitor as a New Class of Insulin Sensitizer
Zhang, Y., & Ye, J. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.06.010 · Cited by 47
Bonini, M. G., & Gantner, B. N. (2013) · IUBMB Life · doi:10.1002/iub.1213 · Cited by 49
Obesity and Asthma in Children: Current and Future Therapeutic Options
Lang, J. E. (2014) · Pediatric Drugs · doi:10.1007/s40272-014-0069-1 · Cited by 49
Carbon Source and Myc Expression Influence the Antiproliferative Actions of Metformin
Javeshghani, S., Zakikhani, M., Austin, S., Bazile, M., Blouin, M., Topisirović, I., St‐Pierre, J., & Pollak, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2907 · Cited by 49
Li, L., Wang, Y., Peng, T., Zhang, K., Lin, C., Han, R., Lu, C., & He, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9120 · Cited by 47
Frandsen, S. K., & Gehl, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181839 · Cited by 47
p21cip1/waf1 Coordinates Autophagy, Proliferation and Apoptosis in Response to Metabolic Stress
Manu, K. A., Cao, P. H. A., Chai, T. F., Casey, P. J., & Wang, M. (2019) · Cancers · doi:10.3390/cancers11081112 · Cited by 47
Targeting liver stage malaria with metformin
Vera, I., Ruivo, M. T. G., Rocha, L. F. L., Marques, S., Bhatia, S. N., Mota, M. M., & Mâncio-Silva, L. (2019) · JCI Insight · doi:10.1172/jci.insight.127441 · Cited by 49
Lactic acidosis induces resistance to the pan-Akt inhibitor uprosertib in colon cancer cells
Barnes, E., Xu, Y., Benito, A., Herendi, L., Siskos, A., Aboagye, E. O., Nijhuis, A. M., & Keun, H. C. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0777-y · Cited by 49
Hypoxia: Turning vessels into vassals of cancer immunotolerance
Schito, L., & Rey, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.015 · Cited by 49
Chong, C. R., & Chabner, B. A. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0286 · Cited by 47
Kiersztan, A., Modzelewska, A., Jarzyna, R., Jagielska, E., & Bryła, J. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00861-4 · Cited by 47
Weerasinghe, H., Simm, C., Djajawi, T. M., Tedja, I., Lo, T. L., Simpson, D. S., Shasha, D., Mizrahi, N., Olivier, F. A. B., Speir, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112522 · Cited by 47
Insulin Signaling in Arthritis
Tripolino, C., Ciaffi, J., Pucino, V., Ruscitti, P., van Leeuwen, N., Borghi, C., Giacomelli, R., Meliconi, R., & Ursini, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.672519 · Cited by 46
Mitochondrial Alterations During Carcinogenesis
Wang, X., Peralta, S., & Moraes, C. T. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00004-6 · Cited by 47
Hilli, M. M. A., Bakkum-Gamez, J. N., Mariani, A., Cliby, W. A., Gree, M. E. M., Weaver, A. L., Dowdy, S. C., & Podratz, K. C. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.11.019 · Cited by 46
Amelioration of aminoglycoside nephrotoxicity requires protection of renal mitochondria
Zorov, D. B. (2010) · Kidney International · doi:10.1038/ki.2010.20 · Cited by 46
Díez, J. J., & Iglesias, P. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04468.x · Cited by 46
Retinal proteome alterations in a mouse model of type 2 diabetes
Ly, A., Scheerer, M. F., Zukunft, S., Muschet, C., Merl‐Pham, J., Adamski, J., de Angelis, M. H., Neschen, S., Hauck, S. M., & Ueffing, M. (2013) · Diabetologia · doi:10.1007/s00125-013-3070-2 · Cited by 46
Pharmacogenetics and personalized treatment of type 2 diabetes
Semiz, S., Dujić, T., & Čaušević, A. (2013) · Biochemia Medica · doi:10.11613/bm.2013.020 · Cited by 46
Dysregulation of mRNA translation and energy metabolism in cancer
Leibovitch, M., & Topisirović, I. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.11.001 · Cited by 46
Metformin for non-small cell lung cancer patients: Opportunities and pitfalls
Lévy, A., & Doyen, J. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.03.001 · Cited by 46
Basavarajappa, S. C., & Nandini, C. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.12.031 · Cited by 47
Role of p53 Family Proteins in Metformin Anti-Cancer Activities
Yi, Y., Zhang, W., Yi, J., & Xiao, Z. J. (2019) · Journal of Cancer · doi:10.7150/jca.30659 · Cited by 47
Martin, S. D., & McGee, S. L. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0207-x · Cited by 48
AMP‐activated protein kinase and the regulation of Ca2+ signalling in O2‐sensing cells
Evans, A. M. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108381 · Cited by 47
Circumventing senescence is associated with stem cell properties and metformin sensitivity
Deschênes‐Simard, X., Parisotto, M., Rowell, M., Le Calvé, B., Igelmann, S., Moineau‐Vallée, K., Saint‐Germain, E., Kalegari, P., Bourdeau, V., Kottakis, F., et al. (2019) · Aging Cell · doi:10.1111/acel.12889 · Cited by 45
Ghosh, S., Lakshmanan, A. P., Hwang, M. J., Kubba, H., Mushannen, A., Triggle, C. R., & Ding, H. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.10.008 · Cited by 45
Wokoun, U., Hellriegel, M., Emons, G., & Gründker, C. (2017) · Oncology Reports · doi:10.3892/or.2017.5491 · Cited by 45
Linden, M. A., Lopez, K. T., Fletcher, J. A., Morris, E. M., Meers, G. M.-E., Siddique, S., Laughlin, M. H., Sowers, J. R., Thyfault, J. P., Ibdah, J. A., et al. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0236 · Cited by 45
Víctor, V. M., Rovira‐Llopis, S., Bañuls, C., Díaz‐Morales, N., Castelló, R., Falcón, R., Gómez, M., Rocha, M., & Hernández‐Mijares, A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0572 · Cited by 46
Na, H.-J., Park, J., Pyo, J.-H., Jeon, H.-J., Kim, Y.-S., Arking, R., & Yoo, M. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.05.004 · Cited by 45
de Mey, S., Jiang, H., Corbet, C., Wang, H., Dufait, I., Ka, L. L., Bastien, E., Verovski, V. N., Gevaert, T., Féron, O., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01073 · Cited by 45
Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
Sportelli, C., Urso, D., Jenner, P. G., & Chaudhuri, К. R. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00556 · Cited by 47
The Role of Mitochondria in Immune-Cell-Mediated Tissue Regeneration and Ageing
Su, Y., Wang, P., & Weng, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052668 · Cited by 45
Shitara, Y., Nakamichi, N., Norioka, M., Shima, H., Kato, Y., & Horie, T. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs330 · Cited by 47
Pharmacologically-Induced Metabolic Acidosis
Liamis, G. L., Milionis, H. J., & Elisaf, M. (2010) · Drug Safety · doi:10.2165/11533790-000000000-00000 · Cited by 45
Convergence of IPMK and LKB1-AMPK Signaling Pathways on Metformin Action
Bang, S., Chen, Y., Ahima, R. S., & Kim, S. F. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1134 · Cited by 45
Wang, G., Chen, L., Qin, S., Zhang, T., Yao, J., Yi, Y., & Deng, L. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac055 · Cited by 45
Emerging roles of fatty acid metabolism in cancer and their targeted drug development
An, Q., Lin, R., Wang, D., & Wang, C. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114613 · Cited by 45
Kim, T. H., Suh, D. H., Kim, M., & Song, Y. S. (2014) · BioMed Research International · doi:10.1155/2014/132702 · Cited by 44
Tan, S. Y., Kelkar, Y., Hadjipanayis, A. G., Shipstone, A., Wynn, T. A., & Hall, J. P. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000137 · Cited by 46
Hutchinson, D. S., Csikasz, R. I., Yamamoto, D. L., Shabalina, I. G., Wikström, P., Wilcke, M., & Bengtsson, T. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.02.006 · Cited by 44
OXPHOS dysfunction regulates integrin- 1 modifications and enhances cell motility and migration
Nunes, J. B., Peixoto, J., Soares, P., Máximo, V., Carvalho, S., Pinho, S. S., Vieira, A. F., Paredes, J., Rego, A. C., Ferreira, I. L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu612 · Cited by 45
AG311, a small molecule inhibitor of complex I and hypoxia-induced HIF-1α stabilization
Bastian, A., Matsuzaki, S., Humphries, K. M., Pharaoh, G. A., Doshi, A., Zaware, N., Gangjee, A., & Ihnat, M. A. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.040 · Cited by 43
Maehara, O., Ohnishi, S., Asano, A., Suda, G., Natsuizaka, M., Nakagawa, K., Kobayashi, M., Sakamoto, N., & Takeda, H. (2019) · Neoplasia · doi:10.1016/j.neo.2019.03.007 · Cited by 44
Stein, B. D., Calzolari, D., Hellberg, K., Hu, Y., He, L., Hung, C., Toyama, E. Q., Ross, D. S., Lillemeier, B. F., Cantley, L. C., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.117 · Cited by 44
Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease
Ladeiras‐Lopes, R., Fontes‐Carvalho, R., Bettencourt, N., Sampaio, F., Gama, V., & Leite-Moreira, A. F. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1025051 · Cited by 44
Sheng, B., Ni, J., Lv, B., Jiang, G., Lin, X., & Li, H. (2023) · Acta Diabetologica · doi:10.1007/s00592-022-02016-5 · Cited by 43
AMPK inhibits liver gluconeogenesis: fact or fiction?
Johanns, M., Hue, L., & Rider, M. H. (2023) · Biochemical Journal · doi:10.1042/bcj20220582 · Cited by 46
Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies
Huang, Y., & Zhou, B. (2023) · Biomedicines · doi:10.3390/biomedicines11051500 · Cited by 42
Adenosine-Mono-Phosphate-Activated Protein Kinase-Independent Effects of Metformin in T Cells
Zarrouk, M., Finlay, D. K., Foretz, M., Viollet, B., & Cantrell, D. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106710 · Cited by 44
Fu, L., Bruckbauer, A., Li, F., Cao, Q., Cui, X., Wu, R., Shi, H., Zemel, M. B., & Xue, B. (2015) · Metabolism · doi:10.1016/j.metabol.2015.03.007 · Cited by 43
Safiulina, D., Peet, N., Seppet, E. K., Zharkovsky, A., & Kaasik, A. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl064 · Cited by 42
Expanding the therapeutic spectrum of metformin: from diabetes to cancer
Coperchini, F., Leporati, P., Rotondi, M., & Chiovato, L. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0370-z · Cited by 43
Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2
Seliger, C., Meyer, A.-L., Renner, K., Leidgens, V., Moeckel, S., Jachnik, B., Dettmer, K., Tischler, U., Gerthofer, V., Rauer, L., et al. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1186316 · Cited by 42
Schommers, P., Thurau, A., Bultmann-Mellin, I., Guschlbauer, M., Klatt, A. R., Rozman, J., Klingenspor, M., de Angelis, M. H., Alber, J., Gründemann, D., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.05.002 · Cited by 42
Noser, A. A., Abdelmonsef, A. H., El-Naggar, M. H., & Salem, M. M. (2021) · Molecules · doi:10.3390/molecules26175332 · Cited by 43
Shoshan‐Barmatz, V., Anand, U., Crystal, E. N., Carlo, M. D., & Shteinfer‐Kuzmine, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730048 · Cited by 42
Anti-flavivirus Properties of Lipid-Lowering Drugs
Farfán-Morales, C. N., Cordero‐Rivera, C. D., Reyes-Ruíz, J. M., Hurtado-Monzón, A. M., Osuna‐Ramos, J. F., González‐González, A. M., Jesús‐González, L. A. D., Palacios-Rápalo, S. N., & del Ángel, R. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.749770 · Cited by 43
Cross Regulation of Sirtuin 1, AMPK, and PPARγ in Conjugated Linoleic Acid Treated Adipocytes
Jiang, S., Wang, W., Miner, J. L., & Fromm, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048874 · Cited by 47
Balancing Risk and Benefit with Oral Hypoglycemic Drugs
Hamnvik, O. R., & McMahon, G. T. (2009) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20116 · Cited by 44
Metformin and pancreatic cancer: Is there a role?
Souza, A. O., Khawaja, K. I., Masud, F., & Saif, M. W. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2948-8 · Cited by 43
Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal
Brynildsen, J. K., Lee, B. G., Perron, I. J., Jin, S., Kim, S. F., & Blendy, J. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707047115 · Cited by 42
Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling
Zhou, X., & Torres, V. E. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.981963 · Cited by 42
He, M., Lu, B., Opoku, M., Zhang, L., Xie, W., Jin, H., Chen, S., Li, Y., & Deng, Z. (2022) · Cells · doi:10.3390/cells11193012 · Cited by 42
Nakashima, K., Takeuchi, K., Chihara, K., Hotta, H., & Sada, K. (2011) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2011.00382.x · Cited by 42
Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells
Bruno, S., Ledda, B., Tenca, C., Ravera, S., Orengo, A. M., Mazzarello, A. N., Pesenti, E., Casciaro, S., Racchi, O., Ghiotto, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4168 · Cited by 42
Gao, A., Fu, Y., Zhang, K., Zhang, M., Jiang, H., Fan, L.-X., Nan, F., Yuan, C., Li, J. X., Zhou, Y., et al. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.04.002 · Cited by 46
Metadata
- Authors
- OWEN, M. R., DORAN, E., & HALESTRAP, A. P.
- Affiliations
- University of Bristol (GB)
- ORCID
- HALESTRAP, Andrew P.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2000-06-07
- Volume
- 348
- Issue
- 3
- Pages
- 607-614
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1221104
- OpenAlex
- W1995069275
- Cited by
- 2,157
- References
- 35
- Citations by year
- 2026: 64 · 2025: 78 · 2024: 92 · 2023: 125 · 2022: 127 · 2021: 157 · 2020: 163 · 2019: 144 · 2018: 142 · 2017: 144 · 2016: 139 · 2015: 126 · 2014: 135 · 2013: 112 · 2012: 75
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UWE Research Repository (UWE Bristol) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, mitochondrial complex I inhibition, mitochondrial respiratory chain, type 2 diabetes, gluconeogenesis, hepatocytes, mitochondrial membrane potential, lactic acidosis, glucose utilization, mechanism of action
- MeSH terms
- Animals, Electron Transport, Gluconeogenesis, Hypoglycemic Agents, Liver, Male, Metformin, Mitochondria, NADH, NADPH Oxidoreductases, Submitochondrial Particles, Tumor Cells, Cultured, Signal Transduction, Rats, Wistar, Electron Transport Complex I, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
